Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Spinelli

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
The Lancet. HIV|June 21, 2021
SARS-CoV-2 vaccination in people with HIVMatthew A Spinelli
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2019
Pre-exposure Prophylaxis Persistence Is a Critical Issue in PrEP ImplementationMatthew A Spinelli, Susan P Buchbinder
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2025
ReplyMatthew A Spinelli, Katerina A Christopoulos
The Lancet. Infectious Diseases|April 17, 2021
Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases - Authors' replyMatthew A Spinelli, George Rutherford, Monica Gandhi
JAMA|October 14, 2024
Preexposure Prophylaxis (PrEP) for HIVMatthew A Spinelli, Kenneth Ngure, Monica Gandhi
Current Opinion in HIV and AIDS|November 13, 2020
The interplay between HIV and COVID-19: summary of the data and responses to dateLillian B Brown, Matthew A Spinelli, Monica Gandhi
Current Opinion in HIV and AIDS|June 28, 2022
Promises and challenges: cabotegravir for preexposure prophylaxisMatthew A Spinelli, Beatriz Grinsztejn, Raphael J Landovitz
JAMA|April 10, 2019
Addressing the Sexually Transmitted Infection and HIV SyndemicMonica Gandhi, Matthew A Spinelli, Kenneth H Mayer
AIDS (London, England)|March 12, 2021
Tenofovir-based PrEP for COVID-19: an untapped opportunity?Colette DeJong, Matthew A Spinelli, Hideaki Okochi, et al.
Current HIV/AIDS Reports|August 5, 2022
COVID-19 Outcomes and Risk Factors Among People Living with HIVMatthew A Spinelli, Benjamin L H Jones, Monica Gandhi
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
The Lancet. HIV|June 21, 2021
SARS-CoV-2 vaccination in people with HIVMatthew A Spinelli
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2019
Pre-exposure Prophylaxis Persistence Is a Critical Issue in PrEP ImplementationMatthew A Spinelli, Susan P Buchbinder
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2025
ReplyMatthew A Spinelli, Katerina A Christopoulos
The Lancet. Infectious Diseases|April 17, 2021
Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases - Authors' replyMatthew A Spinelli, George Rutherford, Monica Gandhi
JAMA|October 14, 2024
Preexposure Prophylaxis (PrEP) for HIVMatthew A Spinelli, Kenneth Ngure, Monica Gandhi
Current Opinion in HIV and AIDS|November 13, 2020
The interplay between HIV and COVID-19: summary of the data and responses to dateLillian B Brown, Matthew A Spinelli, Monica Gandhi
Current Opinion in HIV and AIDS|June 28, 2022
Promises and challenges: cabotegravir for preexposure prophylaxisMatthew A Spinelli, Beatriz Grinsztejn, Raphael J Landovitz
JAMA|April 10, 2019
Addressing the Sexually Transmitted Infection and HIV SyndemicMonica Gandhi, Matthew A Spinelli, Kenneth H Mayer
AIDS (London, England)|March 12, 2021
Tenofovir-based PrEP for COVID-19: an untapped opportunity?Colette DeJong, Matthew A Spinelli, Hideaki Okochi, et al.
Current HIV/AIDS Reports|August 5, 2022
COVID-19 Outcomes and Risk Factors Among People Living with HIVMatthew A Spinelli, Benjamin L H Jones, Monica Gandhi
Pageof 8